Zolax, you are asking for independent verification? The study in Japan on gastric cancer had no connection to BioCurex except providing the historecaf kits. They published their results in the ISOBM journal. ProtoKinetics used the test kits to verify data on breast cancer. They are independent of bioCurex. Abbott ran their analyzer for prostate cancer and published the data at the ISOBM. They are most certainly independent of BioCurex.
I see at least 3 independent verifications of the technology.
We will soon see an abstract published at another international conference on the new manual test just released. It was conducted by the Botkin cancer research center.
I do not think there is any question about the validity of the technology. The only question remaining is how the technology is going to be applied in patient treatment.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.